Back

Atrial fibrillation recurrence rates in patients with transthyretin cardiac amyloidosis undergoing pulmonary vein isolation: a comparative retrospective study with propensity score matching

31 August 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Disease states and mapping techniques: do they affect outcomes of catheter ablation for atrial fibrillation? Rhythm Control, Catheter Ablation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Stefano Valcher

Humanitas Research Hospital, Rozzano (Italy)

7 More presentations in this session

Presentation thumbnail
Role of 3D-electro-anatomical mapping on procedural characteristics and outcomes in pulsed-field ablation for atrial fibrillation
Mr D. Spreen (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Atrial pace mapping with automatic intracardiac pattern matching for non-pulmonary vein trigger ablation: accuracy and feasibility
Mr E. Lian (Kiel, DE)
Abstract Slides Video
Presentation thumbnail
Unipolar electroanatomical mapping outperforms bipolar voltage in detecting LGE areas in the left atrium
Doctor Y. Mohsen (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
High density mapping accuracy and efficiency in atrial fibrillation: real-world outcomes from the SECURE registry
Doctor A. Di Monaco (Acquaviva Delle Fonti, IT)
Abstract Slides Video
Presentation thumbnail
Left atrial substrate modification for persistent atrial fibrillation and left atrial macro or microreentrant tachycardia using a single-shot pulsed field ablation system - a single centre case series
Mr P. Lustig (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Disease states and mapping techniques: do they affect outcomes of catheter ablation for atrial fibrillation?

The Event

Event poster

ESC Congress 2024

31 August 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of rhythm control in wild-type transthyretin cardiac amyloidosis and atrial fibrillation: a retrospective analysis
thumbnail
Congress Presentation
Atrial fibrillation is associated with worse outcome in patients with wild-type transthyretin amyloid cardiomyopathy
thumbnail
Congress Presentation
Trends in prevalence and clinical outcomes of patients with atrial fibrillation and cardiac amyloidosis- from a nationwide registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources